Meeting
2023 ASCO Breakthrough
Effect of spatial transcriptomics on tumor immune microenvironment resistant to immune checkpoint inhibitors in metastatic urothelial carcinoma.
Authors
Tomohiro Iwasawa
Department of Urology, Keio University School of Medicine, Tokyo, Japan
Tomohiro Iwasawa , Nobuyuki Tanaka , Kota Itahashi , Kazuhiro Matsumoto , Shohei Koyama , Hiroyoshi Nishikawa , Mototsugu Oya
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Breast Cancer,Central Nervous System Tumors,Developmental Therapeutics,Genitourinary Cancer,Hematologic Malignancies,Thoracic Cancers,Other Malignancies or Topics
Sub Track
Immunotherapies
Citation
JCO Global Oncology 9, 2023 (suppl 1; abstr 68)
DOI
10.1200/GO.2023.9.Supplement_1.68
Abstract #
68
Poster Bd #
D4
Abstract Disclosures
Similar Posters
Poster
2019 ASCO-SITC Clinical Immuno-Oncology Symposium
Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor (ICI) response in metastatic renal cell carcinoma (mRCC).
First Author: Jason Zhu
Poster
2019 Genitourinary Cancers Symposium
Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor (ICI) response in metastatic renal cell carcinoma (mRCC).
First Author: Jason Zhu
Poster
2024 ASCO Gastrointestinal Cancers Symposium
A transcriptomic approach to explore the immune landscape of patient with pancreatic ductal adenocarcinoma with prognostic impact.
First Author: Jose Antonio Lopez Guerrero
Poster
2023 ASCO Breakthrough
Association of Claudin-1 overexpression with immune exclusion in nasopharyngeal carcinoma and its potential as a novel therapeutic target.
First Author: Eugenia Li Ling Yeo